TASIGNA Adverse Event: Respiratory failure
TASIGNA Adverse Event: Respiratory failure is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TASIGNA; Product category: Drug; Primary reaction: Respiratory failure.
| Primary drug | TASIGNA |
|---|---|
| Product category | Drug |
| Primary reaction | Respiratory failure |
| All reactions | Respiratory failure; Pneumonia; Haemoglobin decreased; Chronic myeloid leukaemia transformation; Platelet count decreased |
| Seriousness | Serious |
| Patient outcome | Fatal |
| Patient sex | Female |
| All drugs reported | TASIGNA; CHEMOTHERAPEUTICS |
| Reporter country | COUNTRY NOT SPECIFIED |
| Reporter type | 5 |
| Report date | 20140312 |
| Report ID | 10004917 |
$299/mo
Try FDATracker →